PhRMA, the Pharmaceutical Research and Manufacturers of America, represents the country’s leading innovative biopharmaceutical research companies. Our members are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. New medicines are an integral part of the health care system, providing doctors and patients with safe and effective treatment options, and improving quality of life.
Key Facts About Innovative Medicines
PhRMA was formed in 1958 to represent America’s biopharmaceutical research companies and help promote smart public policy that supports medical research to address patient needs. Headquartered in Washington, D.C., with offices in leading biopharmaceutical research communities, PhRMA advocates in the United States and around the world for policies that support the discovery and development of innovative medicines. Our policy priorities include: explaining the increased complexity and risk of the research and development process; reinforcing the need for investment in R D; ensuring broad access to and appropriate use of medicines; and emphasizing the importance of strong intellectual property incentives for new medicines.
Our 12 offices are located across the United States and in Tokyo, Japan, and Dubai, United Arab Emirates.